CLINICAL SIGNIFICANCE OF ACTIVIN A AND MYOSTATIN IN PATIENTS WITH PANCREATIC ADENOCARCINOMA AND PROGRESSIVE WEIGHT LOSS.
- Published in:
- Journal of Physiology & Pharmacology, 2020, v. 71, n. 1, p. 105, doi. 10.26402/jpp.2020.1.10
- By:
- Publication type:
- Article